Promising new agents in the treatment of non small cell lung cancer

被引:43
|
作者
Edelman, MJ [1 ]
Gandara, DR [1 ]
机构
[1] UNIV CALIF DAVIS,DIV HEMATOL & ONCOL,DAVIS,CA 95616
关键词
lung cancer; paclitaxel; docetaxel; CPT-11; topotecan; vinorelbine; gemcitabine;
D O I
10.1007/s002800050402
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A number of new drugs and drug classes have recently become available for clinical testing which demonstrate significant antitumor activity in non-small cell lung cancer. The preclinical rationale, mechanism of action, toxicity profile and results of early trials of paclitaxel, docetaxel, edatrexate, CPT-11, topotecan, vinorelbine and gemcitabine in non-small cell lung cancer are reviewed.
引用
收藏
页码:385 / 393
页数:9
相关论文
共 50 条